Home Ventilators

Covers home noninvasive and invasive ventilators for long‑term positive‑pressure ventilation (including AVAPS) delivered via masks, mouthpieces, helmets, or invasive airways. Key populations include patients with neuromuscular disease, severe thoracic cage disorders, obesity hypoventilation syndrome (BMI ≥30) and select severe COPD cases, but coverage requires stability with qualifying testing (e.g., awake ABG with PaCO2 ≥45 mmHg or sleep oximetry criteria), is initially authorized for a 3‑month period, excludes use intended for RAD/CPAP, and continued coverage requires ≥4 hours average use/24h and documented clinical benefit.

"Home noninvasive ventilation (NIV) for administration of positive pressure via interfaces such as nasal masks, orofacial masks, full face masks, mouthpieces, nasal pillows, or helmets."

Sign up to see full coverage criteria, indications, and limitations.